GRAFT VERSUS HOST DISEASE (GVHD)
Clinical trials for GRAFT VERSUS HOST DISEASE (GVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE (GVHD) trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lung protein tame severe graft-versus-host disease?
Disease control CompletedThis phase 3 trial investigates whether adding alpha-1 antitrypsin (AAT) to standard corticosteroid therapy improves outcomes for people with high-risk acute graft-versus-host disease (GVHD) after a stem cell transplant. Participants receive either AAT plus steroids or a placebo …
Matched conditions: GRAFT VERSUS HOST DISEASE (GVHD)
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a new pill tame GVHD after transplant?
Disease control CompletedThis large Phase 3 study tested whether adding the drug itacitinib to standard steroids helps control acute graft-versus-host disease (GVHD) in people who had a stem cell transplant for blood cancer. About 439 participants received either itacitinib or a placebo along with steroi…
Matched conditions: GRAFT VERSUS HOST DISEASE (GVHD)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 26, 2026 13:19 UTC